Fmoc-α-Me-Leu-OH
Fmoc-α-Me-Leu-OH is a leucine derivative with an Fmoc protecting group, which can be used to synthesize peptides with oxytocin receptor agonist activity[1].
Product Specifications
CAS Number
[312624-65-0]
UNSPSC
12352209
Hazard Statement
H302, H315, H319, H335
Target
Amino Acid Derivatives
Type
Peptides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/fmoc-α-me-leu-oh.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)C[C@](C(O)=O)(C)NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O
Molecular Formula
C22H25NO4
Molecular Weight
367.44
Precautions
H302, H315, H319, H335
References & Citations
[1]Caterina Bissantz, et al. Peptides as oxytocin agonists. WO2015185584A1. 2015-06-03
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15369002 1 Vial
Lentiviral human IRAK1BP1 sgRNA gene knockout kit - Lentiviral human IRAK1BP1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details ![5- (2-Hydroxyphenyl) -3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
014293 10 mg
5- (2-Hydroxyphenyl) -3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
Sign In for Pricing
View Details MBS6317830-01 0.1 mL
LZP (OIT3, LZP, Oncoprotein-induced transcript 3 protein, Liver-specific zona pellucida domain-containing protein) (MaxLight 490)
Sign In for Pricing
View Details